MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib

• मुख्य लेखकों: Paola Stiuso (लेखक), Nicoletta Potenza (लेखक), Angela Lombardi (लेखक), Ida Ferrandino (लेखक), Antonio Monaco (लेखक), Silvia Zappavigna (लेखक), Daniela Vanacore (लेखक), Nicola Mosca (लेखक), Filomena Castiello (लेखक), Stefania Porto (लेखक), Raffaele Addeo (लेखक), Salvatore Del Prete (लेखक), Ferdinando De Vita (लेखक), Aniello Russo (लेखक), Michele Caraglia (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2015-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Hepatocellular carcinoma (HCC) is the third cause of cancer-related deaths worldwide. Sorafenib is the only approved drug for patients with advanced HCC but has shown limited activity. microRNAs (miRs) have been involved in several neoplasms including HCC suggesting their use or targeting as good to...